Healthcare provider profile · identity verified

William E Cartwright, M.D.

Family Practice · PARKERSBURG, WV · NPI 1831147263

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	588	159
Levothyroxine Sodium	Levothyroxine Sodium	460	125
Amlodipine Besylate	Amlodipine Besylate	370	111
Pantoprazole Sodium	Pantoprazole Sodium	324	84
Omeprazole	Omeprazole	274	77
Duloxetine Hcl	Duloxetine Hcl	268	57
Metoprolol Tartrate	Metoprolol Tartrate	237	61
Lisinopril	Lisinopril	225	66
Metformin Hcl	Metformin Hcl	218	58
Gabapentin	Gabapentin	211	55
Losartan Potassium	Losartan Potassium	202	63
Escitalopram Oxalate	Escitalopram Oxalate	185	52
Carvedilol	Carvedilol	171	49
Meloxicam	Meloxicam	171	58
Tramadol Hcl	Tramadol Hcl	165	51
Tamsulosin Hcl	Tamsulosin Hcl	163	56
Rosuvastatin Calcium	Rosuvastatin Calcium	159	56
Famotidine	Famotidine	158	38
Potassium Chloride	Potassium Chloride	137	29
Metoprolol Succinate	Metoprolol Succinate	136	43
Fluoxetine Hcl	Fluoxetine Hcl	121	33
Hydralazine Hcl	Hydralazine Hcl	121	35
Ezetimibe	Ezetimibe	119	36
Simvastatin	Simvastatin	117	37
Clopidogrel	Clopidogrel Bisulfate	116	42
Montelukast Sodium	Montelukast Sodium	112	30
Eliquis	Apixaban	106	22
Myrbetriq	Mirabegron	102	suppressed
Colestipol Hcl	Colestipol Hcl	100	14
Valsartan	Valsartan	99	31
Alprazolam	Alprazolam	96	29
Jardiance	Empagliflozin	95	26
Fluticasone Propionate	Fluticasone Propionate	93	37
Allopurinol	Allopurinol	90	26
Sertraline Hcl	Sertraline Hcl	90	31
Furosemide	Furosemide	89	27
Olmesartan Medoxomil	Olmesartan Medoxomil	89	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	33
Clonazepam	Clonazepam	86	17
Spironolactone	Spironolactone	85	25
Pioglitazone Hcl	Pioglitazone Hcl	84	28
Hydrochlorothiazide	Hydrochlorothiazide	78	24
Prednisone	Prednisone	74	48
Memantine Hcl	Memantine Hcl	72	suppressed
Buspirone Hcl	Buspirone Hcl	71	27
Donepezil Hcl	Donepezil Hcl	69	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	69	suppressed
Ozempic	Semaglutide	68	15
Nifedipine Er	Nifedipine	66	suppressed
Ropinirole Hcl	Ropinirole Hcl	62	15
Sucralfate	Sucralfate	60	23
Topiramate	Topiramate	59	suppressed
Atenolol	Atenolol	58	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	17
Citalopram Hbr	Citalopram Hydrobromide	57	18
Doxycycline Hyclate	Doxycycline Hyclate	56	44
Raloxifene Hcl	Raloxifene Hcl	56	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	16
Trazodone Hcl	Trazodone Hcl	54	17
Mirtazapine	Mirtazapine	53	17
Metformin Hcl Er	Metformin Hcl	51	13
Zolpidem Tartrate	Zolpidem Tartrate	50	12
Amoxicillin	Amoxicillin	48	34
Doxazosin Mesylate	Doxazosin Mesylate	45	13
Bupropion Xl	Bupropion Hcl	44	14
Celecoxib	Celecoxib	44	15
Pregabalin	Pregabalin	44	13
Carbidopa-Levodopa Er	Carbidopa/Levodopa	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	12
Warfarin Sodium	Warfarin Sodium	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	31
Mounjaro	Tirzepatide	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Cephalexin	Cephalexin	33	20
Nitroglycerin	Nitroglycerin	32	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Nystatin	Nystatin	30	18
Ketoconazole	Ketoconazole	29	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Fluconazole	Fluconazole	27	13
Linzess	Linaclotide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	18
Venlafaxine Hcl Er	Venlafaxine Hcl	27	11
Lovastatin	Lovastatin	26	suppressed
Finasteride	Finasteride	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Lorazepam	Lorazepam	22	13
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Azithromycin	Azithromycin	20	18
Januvia	Sitagliptin Phosphate	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Metolazone	Metolazone	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Cefdinir	Cefdinir	15	14
Levofloxacin	Levofloxacin	15	14
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Ramipril	Ramipril	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	11
Enalapril Maleate	Enalapril Maleate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error